These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11038372)

  • 21. p300/CBP is required for transcriptional induction by interleukin-4 and interacts with Stat6.
    Gingras S; Simard J; Groner B; Pfitzner E
    Nucleic Acids Res; 1999 Jul; 27(13):2722-9. PubMed ID: 10373589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetylation of conserved lysines in bovine papillomavirus E2 by p300.
    Quinlan EJ; Culleton SP; Wu SY; Chiang CM; Androphy EJ
    J Virol; 2013 Feb; 87(3):1497-507. PubMed ID: 23152516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adeno-associated virus type 2 rep protein inhibits human papillomavirus type 16 E2 recruitment of the transcriptional coactivator p300.
    Marcello A; Massimi P; Banks L; Giacca M
    J Virol; 2000 Oct; 74(19):9090-8. PubMed ID: 10982355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins.
    Peng YC; Breiding DE; Sverdrup F; Richard J; Androphy EJ
    J Virol; 2000 Jul; 74(13):5872-9. PubMed ID: 10846067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative regulation of the bovine papillomavirus E5, E6, and E7 oncogenes by the viral E1 and E2 genes.
    Vande Pol SB; Howley PM
    J Virol; 1995 Jan; 69(1):395-402. PubMed ID: 7983735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein.
    Scolnick DM; Chehab NH; Stavridi ES; Lien MC; Caruso L; Moran E; Berger SL; Halazonetis TD
    Cancer Res; 1997 Sep; 57(17):3693-6. PubMed ID: 9288775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular factors are required to activate bovine papillomavirus-1 early gene transcription and to establish viral plasmid persistence but are not required for cellular transformation.
    Haugen TH; Lace MJ; Ishiji T; Sameshima A; Anson JR; Turek LP
    Virology; 2009 Jun; 389(1-2):82-90. PubMed ID: 19410271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding and modulation of p53 by p300/CBP coactivators.
    Lill NL; Grossman SR; Ginsberg D; DeCaprio J; Livingston DM
    Nature; 1997 Jun; 387(6635):823-7. PubMed ID: 9194565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human homologue of yeast Rad23 protein A interacts with p300/cyclic AMP-responsive element binding (CREB)-binding protein to down-regulate transcriptional activity of p53.
    Zhu Q; Wani G; Wani MA; Wani AA
    Cancer Res; 2001 Jan; 61(1):64-70. PubMed ID: 11196199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity.
    Sang N; Avantaggiati ML; Giordano A
    J Cell Biochem; 1997 Sep; 66(3):277-85. PubMed ID: 9257185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain.
    Iioka T; Furukawa K; Yamaguchi A; Shindo H; Yamashita S; Tsukazaki T
    J Bone Miner Res; 2003 Aug; 18(8):1419-29. PubMed ID: 12929931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of the CBP but not the p300 co-activator by human T-lymphotropic virus type-2 Tax for p53 inhibition.
    Meertens L; Pise-Masison C; Quere N; Brady J; Gessain A; Mahieux R
    Oncogene; 2004 Jul; 23(32):5447-58. PubMed ID: 15156194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation.
    Hebner C; Beglin M; Laimins LA
    J Virol; 2007 Dec; 81(23):12740-7. PubMed ID: 17898049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1.
    Bhattacharya S; Michels CL; Leung MK; Arany ZP; Kung AL; Livingston DM
    Genes Dev; 1999 Jan; 13(1):64-75. PubMed ID: 9887100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.
    Ghosh AK; Yuan W; Mori Y; Varga J
    Oncogene; 2000 Jul; 19(31):3546-55. PubMed ID: 10918613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel transcriptional repression domain mediates p21(WAF1/CIP1) induction of p300 transactivation.
    Snowden AW; Anderson LA; Webster GA; Perkins ND
    Mol Cell Biol; 2000 Apr; 20(8):2676-86. PubMed ID: 10733570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a second transforming function in bovine papillomavirus type 1 E6 and the role of E6 interactions with paxillin, E6BP, and E6AP.
    Das K; Bohl J; Vande Pol SB
    J Virol; 2000 Jan; 74(2):812-6. PubMed ID: 10623743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of transcriptional regulatory properties of p53 by HPV E6.
    Crook T; Fisher C; Masterson PJ; Vousden KH
    Oncogene; 1994 Apr; 9(4):1225-30. PubMed ID: 8134125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p300/MDM2 complexes participate in MDM2-mediated p53 degradation.
    Grossman SR; Perez M; Kung AL; Joseph M; Mansur C; Xiao ZX; Kumar S; Howley PM; Livingston DM
    Mol Cell; 1998 Oct; 2(4):405-15. PubMed ID: 9809062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Ewing's sarcoma gene product functions as a transcriptional activator.
    Rossow KL; Janknecht R
    Cancer Res; 2001 Mar; 61(6):2690-5. PubMed ID: 11289149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.